Vident Advisory’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
+13,998
| New | +$162K | ﹤0.01% | 1527 |
|
|
2024
Q3 | – | Sell |
-11,999
| Closed | -$233K | – | 1553 |
|
|
2024
Q2 | $233K | Buy |
11,999
+4,171
| +53% | +$81.1K | 0.01% | 1218 |
|
|
2024
Q1 | $294K | Buy |
7,828
+798
| +11% | +$29.9K | 0.01% | 1033 |
|
|
2023
Q4 | $393K | Sell |
7,030
-117
| -2% | -$6.55K | 0.01% | 890 |
|
|
2023
Q3 | $295K | Buy |
+7,147
| New | +$295K | 0.01% | 918 |
|